These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2142574

  • 1. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
    Hümpel M, Täuber U, Kuhnz W, Pfeffer M, Brill K, Heithecker R, Louton T, Steinberg B, Seifert W, Schütt B.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
    [Abstract] [Full Text] [Related]

  • 2. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
    Hammond GL, Bocchinfuso WP, Orava M, Smith CL, van den Ende A, van Enk A.
    Contraception; 1994 Oct; 50(4):301-18. PubMed ID: 7813219
    [Abstract] [Full Text] [Related]

  • 3. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 4. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, Jütting G.
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [Abstract] [Full Text] [Related]

  • 6. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months.
    Dibbelt L, Knuppen R, Jütting G, Heimann S, Klipping CO, Parikka-Olexik H.
    Contraception; 1991 Jan; 43(1):1-21. PubMed ID: 1825969
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.
    Hümpel M, Tüber U, Kuhnz W, Pfeffer M, Brill K, Heithecker R, Louton T, Steinberg B.
    Horm Res; 1990 Jan; 33(1):35-9. PubMed ID: 2142929
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W, Schütt B, Power J, Back DJ.
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
    Jung-Hoffman C, Kuhl H.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2183-97. PubMed ID: 2147819
    [Abstract] [Full Text] [Related]

  • 10. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
    Kuhnz W, Pfeffer M, al-Yacoub G.
    J Steroid Biochem; 1990 Feb; 35(2):313-8. PubMed ID: 2308344
    [Abstract] [Full Text] [Related]

  • 11. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C, Fitzner M, Kuhl H.
    Horm Res; 1991 Feb; 36(5-6):238-46. PubMed ID: 1823082
    [Abstract] [Full Text] [Related]

  • 12. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive.
    Täuber U, Kuhnz W, Hümpel M.
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1414-20. PubMed ID: 2220966
    [Abstract] [Full Text] [Related]

  • 14. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R.
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.
    Dibbelt L, Knuppen R, Kuhnz W, Jütting G.
    Arzneimittelforschung; 1992 Sep; 42(9):1146-52. PubMed ID: 1445484
    [Abstract] [Full Text] [Related]

  • 17. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 18. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
    Sobbrio GA, Granata A, Granese D, D'Arrigo F, Panacea A, Nicita R, Pullè C, Trimarchi F.
    Clin Exp Obstet Gynecol; 1991 Sep; 18(1):43-5. PubMed ID: 1829029
    [Abstract] [Full Text] [Related]

  • 19. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
    Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M.
    Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
    [Abstract] [Full Text] [Related]

  • 20. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.